Paroxetine Tablet, Film Coated
Product Images NDC 55289-972

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Paroxetine (NDC 55289-972). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Pd-rx Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

55289972 (55289972)

Paroxetine USP 20 mg film-coated tablets packaging label from PD-Rx Pharmaceuticals, Inc., containing 30 tablets. The label includes NDC 55289-972-30 and displays medication warnings, lot number H21A42, and expiration date 11/2022. Instructions and storage warnings are also present on the label.*

FDA Label Image

9d3352de B6ab 4118 A714 54875d85b0c5 01

Chemical structure of paroxetine hydrochloride, showing the molecular arrangement including a fluorophenyl group, a piperidine ring, and a methylenedioxybenzene moiety.*

FDA Label Image

9d3352de B6ab 4118 A714 54875d85b0c5 02

A chart showing fold changes and 90% confidence intervals for pharmacokinetic parameters Cmax and AUC of Paroxetine when taken with various interacting drugs including Pimozide 2 mg, Desipramine 100 mg, Propranolol 80 mg twice daily, Digoxin 0.25 mg once daily, and Phenytoin 300 mg. The x-axis represents change relative to reference on a logarithmic scale from 0.1 to 10.*

FDA Label Image

9d3352de B6ab 4118 A714 54875d85b0c5 03

A fold change chart depicting the pharmacokinetic effects (Cmax and AUC) of various interacting drugs—Cimetidine 300 mg TID, Phenobarbital 100 mg QD, Phenytoin 300 mg QD, Digoxin 0.25 mg QD, and Diazepam 5 mg TID—relative to reference. The graph shows fold change values and 90% confidence intervals for each drug interaction.*

FDA Label Image

9d3352de B6ab 4118 A714 54875d85b0c5 04

A forest plot showing fold change and 90% confidence intervals for pharmacokinetic parameters (Cmax, AUC, Cmin) of Paroxetine in various populations including mild, moderate, and severe renal impairment, hepatic impairment, age groups over 65 years at different doses, and males, relative to a reference.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.